Lundorff et al; Prognostic Predictors in Women With Heart Failure
A ccording to the latest update from the American Heart Association, the prevalence of heart failure (HF) in the United States in the period from 2011 to 2014 was 6.5 million. 1 Women constituted 66.6%. Of the patients who died from HF, 55.8% were women suggesting more focus is needed on this topic.
Several studies have documented sex-specific differences in cardiac structure and function. Women display more preserved left ventricular ejection fraction (LVEF) [2] [3] [4] [5] [6] [7] and more diastolic dysfunction 2, 6 compared with men. Hence, women have been found to have higher global longitudinal strain (GLS), 8 higher global circumferential strain (GCS), 2 greater arterial stiffness, 2,4,9-12 greater LV diastolic and systolic stiffness, 2, 9 and lower LV mass index (LVMI). 3, 5, 9 We have previously investigated the prognostic value of conventional and novel echocardiographic parameters in patients with HF with reduced EF (HFrEF). 8 In the same cohort as the present, we found that GLS was a strong predictor of mortality in male patients with HFrEF, questioning the superiority of LVEF. 8 Similar results were presented in a study including a low-risk general population. 13 However, in neither of the studies did GLS predict adverse cardiovascular outcomes as effectively in women. Thus, it seems the prognostic value of echocardiographic measures differs in men and women, suggesting a more sex-specific approach to patients with HF could be relevant.
The aim of this study was to investigate sex-specific differences in cardiac structure and function and identify prognostic echocardiographic measures in women with HFrEF.
METHODS

Data Availability
This study is based on human data, which is governed by the Danish Data Protection Agency. Therefore, authors are not able to grant access to the data for purposes of reproducing the results or replicating the procedures. Researchers who wish to gain access to the data are required to file a formal application to the Danish Data Protection Agency.
Study Population
A total of 1102 patients referred to the Gentofte Hospital HFrEF out-patient clinic in the period from 2005 to 2013 were enrolled in this study. All patients had an LVEF of 45% or less at referral. We included patients with an echocardiographic examination performed no >1 year before admittance (median: 30 days before admittance, interquartile range=6 to 56 days before admittance) who had an LVEF of 40% or less according to current HFrEF guidelines. 14 A total of 968 patients had echocardiographic images eligible for analysis (22 patients did not have an echocardiographic examination within 1 year from admittance, 15 were excluded because of inadequate quality of images and 97 patients had an LVEF >40%). Information on mortality status was collected from the Danish National Registry of Mortality and follow-up was 100%. A more detailed description on the study population is available as Data Supplement.
Echocardiography
Transthoracic echocardiography was performed with Vivid 7 or 9 ultrasound machines (GE Healthcare, Little Chalfont, United Kingdom) by trained sonographers. By a single investigator blinded to all baseline data, digitized images were analyzed using an offline image-analysis system (Echopac version 12, GE Healthcare).
Conventional and Color Tissue Doppler Echocardiography
A detailed description on the methods used for conventional and tissue Doppler echocardiography is available in the Data Supplement.
Tricuspid annular plane systolic excursion (TAPSE) was measured from M-mode in the apical 4-chamber view to determine motion of the lateral tricuspid annulus (Figure 1) .
Peak inflow velocities of early diastolic left ventricular filling (E) and atrial diastolic left ventricular filling (A) were assessed from pulsed wave Doppler recordings in the apical 4-chamber view (Figure 2 ). Peak early diastolic mitral annular
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velocity (e′) was measured using pulsed wave Tissue Doppler imaging from septal and lateral mitral annular sites in the apical 4-chamber view (Figure 3 ). The mean value was averaged from septal and lateral tissue velocities and LV filling pressure (E/e′ ratio) was then estimated. 15 LV diastolic stiffness, defined as LV diastolic elastance (Ed), was calculated as E/e′ divided by LV end-diastolic volume (LVEDV) and was subsequently indexed to body surface area (BSA), Ed=((E/e′)/LVEDV)/BSA.
Cardiac Time Intervals
Cardiac time intervals were obtained by color Tissue Doppler imaging M-mode through the mitral valve and measured directly from the color chart ( Figure 4 ). This method has previously been validated, [16] [17] [18] and it has proven superior to conventional methods of obtaining cardiac time intervals. [17] [18] [19] Isovolumetric relaxation time (IVRT) was defined as the time from aortic valve closure to mitral valve opening. For more details see the Data Supplemet.
Speckle Tracking Echocardiography
Two-dimensional speckle tracking echocardiography images for LV myocardial strain and strain rate were analyzed in the apical 2-, 3-, and 4-chamber views. Mean framerate was 74 frames/s (SD: 18 frames/s). LV GLS was calculated as an average of strain values from the available views. LV circumferential speckle tracking was assessed from the parasternal short axis view at the midventricular level. GCS and GCS rate were calculated subsequently. Right ventricle (RV) strain was obtained by 2-dimensional speckle tracking echocardiography in the apical 4-chamber view from a 6-segment speckle tracking model (basal RV free wall, mid RV free wall, apical RV free wall, apical septum, mid septum, and basal septum). RV GLS and RV free wall strain (FWS) were calculated as the average strain from available segments. For a more detailed description see the Data Supplement.
Statistics
STATA version SE 13.0 (StataCorp, Texas) was used for the statistical analyses. Tables 1 and 2 show baseline characteristics according to sex. In Table 3 and Table I in the Data Supplement, Cox regression analyses were run to assess the prognostic value of clinical and echocardiographic measures. In Table 3 in a final multivariable model (Table 3 , model 2) adjusted for the same clinical variables as in model 1 in addition to LVEF and TAPSE in women and the following variables in men: LVEF, LVMI, LV internal dimensions in diastole, left atrial volume index, TAPSE, deceleration time, ejection time, s′, e′, a′, GCS, GLS, and RV FWS. A more detailed description of all the statistical methods used is available in the Data Supplement.
Ethics
The study was approved by the Danish Data Protection Agency, journal no. 03240 (I-Suite), ID: GEH-2014-047. Retrospectives studies do not require written informed consent in Denmark.
RESULTS
Baseline Characteristics of the Study Population Stratified According to Sex
Of the 968 patients included in this study 259 (26.7%) were women. Table 1 shows that women were significantly older (P=0.012) and had higher total cholesterol (P<0.001). Men had significantly larger body mass index (P<0.001) and were more commonly diagnosed with ischemic cardiomyopathy (P=0.027), diabetes mellitus (P=0.05), and previous coronary artery bypass graft surgery (P<0.001; Table 1 ). Echocardiographic measures are presented in Table 2 , revealing that women displayed significantly higher LVEF (P=0.004), GLS (P<0.001), and GCS (P<0.001), whereas interventricular septum thickness at end-diastole (IVSd), LV internal dimensions at end-diastole, LV posterior wall thickness at end-diastole, and LVMI were significantly higher in men (P<0.001, P<0.001, P=0.004, and P<0.001, respectively). Men displayed significantly larger left atrial volume index (P=0.002), LV end-systolic volume (P<0.001), and LVEDV (P<0.001), however, when LV volumes were indexed to BSA no significant sex difference was observed (LV endsystolic volume, P=0.48 and LVEDV, P=0.87). Women presented with significantly lower e′ (P<0.001), higher E/e′ (P=0.004), and higher Ed (P<0.001). All echocardiographic sex differences were independent of the clinical differences observed in Table 1 (Table 2 ).
Outcome and Follow-Up
During follow-up (median: 41 months, interquartile range: 22-57 months) 163 patients (16.8 %) died. Of these 163 events, 37 occurred in women (14.3%) and 126 in men (17.8 %). Follow-up was 100%. Table I in the Data Supplement shows results from univariable Cox regression analyses performed on clinical and echocardiographic variables. These unadjusted models reveal that women who died during follow-up were older, had lower mean arterial pressure and were more often diagnosed with the following: atrial fibrillation, diabetes mellitus, ischemic cardiomyopathy, previous myocardial infarction, and coronary artery bypass graft surgery (Table I in the Data Supplement). The following echocardiographic measures were significant univariable predictors of outcome in women: TAPSE (P<0.001), E (P=0.019), E/e′ (P=0.033), IVRT (P=0.004), s′ (P=0.042), a′ (P=0.018), RV GLS (P=0.002), and RV FWS (P=0.003; Table I in the Data Supplement). The highest C statistics were displayed by TAPSE, RV FWS, and RV GLS in women, whereas LVEF and GLS showed the highest C statistics in men.
Predictors of Outcome in Women and Men
Patients were divided into 2 groups according to the clinical cutoff for abnormal TAPSE (17 mm). Univariable Cox analysis showed that women with TAPSE <17 mm displayed a 3× greater risk of death when compared with women with TAPSE ≥17 mm ( Figure 5A ). Figure 5B Values are mean±SD or n (%). BMI indicates body mass index; CABG, coronary artery bypass graft; HFrEF, heart failure with reduced ejection fraction; ICD, implantable cardioverter-defibrillator; MAP, mean arterial pressure; MI, myocardial infarction; and PTCA, percutaneous transluminal coronary angioplasty.
shows that men with abnormal TAPSE (TAPSE <17 mm) displayed a ≈2× greater risk of death as compared with men with normal TAPSE. After covariate adjustment, TAPSE was not a significant predictor of mortality in men ( Figure 5B) .
We found that sex modified the prognostic value of IVRT, LVEF, and LV GLS (Table I in the Data Supplement). Hence, in univariable Cox analyses, a shorter IVRT was significantly closely associated with mortality in women ( Figure 6A ) whereas changes in LVEF and GLS were significantly more closely associated with outcome in men ( Table I in In a multivariable model (Table 3 , model 1) adjusting for age, mean arterial pressure, diabetes mellitus, atrial fibrillation/flutter, and ischemic cardiomyopathy in women, the following variables were significant predictors of all-cause mortality (P<0.05): LVEF, TAPSE, IVRT, s′, a′, RV GLS, and RV FWS. A similar multivariable model was run for men adjusting for age, heart rate, body mass index, mean arterial pressure, total cholesterol, atrial fibrillation/flutter, diabetes mellitus, percutaneous transluminal coronary angioplasty, and pacemaker or implantable cardioverter-defibrillator. In men, the following variables Values are mean±SD. a′ indicates average atrial diastolic velocity; BMI, body mass index; CABG, coronary artery bypass graft; DT, deceleration time of early diastolic ventricular inflow; e′, average peak early diastolic mitral annular velocity (TDI); E/e′ ratio, left ventricular filling pressure; E, peak transmitral early diastolic inflow velocity; Ed, left ventricular diastolic elastance; ET, ejection time; FWS, free wall strain; GCS, global circumferential strain; GLS, global longitudinal strain; HFrEF, heart failure with reduced ejection fraction; IVCT, isovolumetric contraction time; IVRT, isovolumetric relaxation time; IVSd, interventricular septum thickness at end-diastole; LAVI, left atrial volume index; LVEDV, left ventricular end-diastolic volume; LVEF, LV ejection fraction; LVESV, LV end-systolic volume; LVIDd, LV internal dimensions in diastole; LVMI, LV mass index; LVPWd, LV posterior wall thickness in diastole; s′, average peak systolic mitral annular velocity (TDI); TAPSE, tricuspid annular plane systolic excursion; and TDI, Tissue Doppler imaging.
*Adjusted for age, BMI, total cholesterol, diabetes mellitus, ischemic cardiomyopathy, and CABG surgery. a′ indicates average atrial diastolic velocity; BMI, body mass index; DT, deceleration time of early diastolic ventricular inflow; e′, average peak early diastolic mitral annular velocity (TDI); E/e′ ratio, left ventricular filling pressure; E, peak transmitral early diastolic inflow velocity; ET, ejection time; FWS, free wall strain; GCS, global circumferential strain; GLS, global longitudinal strain; ICD, implantable cardioverter-defibrillator; IVCT, isovolumetric contraction time; IVRT, isovolumetric relaxation time; LAVI, left atrial volume index; LVEF, left ventricular ejection fraction; LVEDV, LV end-diastolic volume; LVESV, LV end-systolic volume; LVIDd, LV internal dimensions in diastole; LVMI, LV mass index; LVPWd, LV posterior wall thickness in diastole; MAP, mean arterial pressure; PTCA, percutaneous transluminal coronary angioplasty; s′, average peak systolic mitral annular velocity (TDI); TAPSE, tricuspid annular plane systolic excursion; and TDI, Tissue Doppler imaging. *Model 1 is adjusted for significant clinical variables (P≤0.2) from Table I in the Data Supplement. In women: age, MAP, diabetes mellitus, atrial fibrillation/ flutter, and ischemic cardiomyopathy. In men: age, heart rate, BMI, MAP, total cholesterol, atrial fibrillation/flutter, diabetes mellitus, PTCA, pacemaker, and ICD. †Model 2 is adjusted for the same clinical variables as in model 1 in addition to LVEF and TAPSE in women and the following variables in men: LVEF, LVMI, LVIDd, LAVI, TAPSE, deceleration time, ejection time, s′, e′, a′, GCS, GLS, and RV FWS. revealed to carry significant prognostic information (P<0.05): LVEF, left atrial volume index, LV end-systolic volume, LVEDV, TAPSE, ejection time, s′, e′, a′, LV GLS, LV GCS, RV GLS, and RV FWS (Table 3 , model 1). In a final multivariable model, we adjusted for the same variables as in model 1 with the addition of LVEF and TAPSE in women and LVEF, LVMI, LV internal dimensions in diastole, left atrial volume index, TAPSE, deceleration time, ejection time, s′, e′, a′, LV GLS, LV GCS, and RV FWS in men (Table 3, 
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DISCUSSION
In this large-scale study of patients with HFrEF, we demonstrate the following (1) women display more impaired LV diastolic function when compared with men, in whom LV systolic function is more impaired. (2) TAPSE and IVRT offer prognostic information in women, whereas LVEF and GLS seem to be better predictors of mortality in men.
Diastolic Dysfunction in Women
It is recognized that cardiovascular stiffness 2, 4, 7, [9] [10] [11] [12] and LV diastolic dysfunction 2, 6 are more often observed in women. This is in concordance with our results, where women displayed lower e′, higher E velocity, and increased left-sided filling pressures (E/e′). Women also showed more preserved LVEF, higher GLS, GCS, and lower LVMI; hence, we confirm previous studies of both healthy women 3, 6, 7, 9 and women with cardiovascular diseases 2, 5 indicating that systolic function is more preserved and diastolic function more impaired in women when compared with men.
Predictors of Outcome
After multivariable adjustment, shorter IVRT was shown to carry significant prognostic information in women (P=0.001). Accordingly, for every 5 ms decrease in IVRT, there was a 7% increase in mortality. Women displayed higher LV filling pressures than men, and in the setting of high LV filling pressure, a short IVRT implies a restrictive filling pattern and more severe diastolic dysfunction. 20 Figure 6A shows that with decreasing values of IVRT there was a radical increase in mortality for women, whereas in men a short IVRT was less associated with outcome. Sex significantly modified the prognostic value of IVRT (P=0.020), indicating that impaired diastolic function, quantified by IVRT, is an independent risk factor in women but not in men.
The prognostic value of TAPSE is consistent with our findings of women having impaired diastolic function. Passive backward transmission of elevated left-sided filling pressures occurring as a consequence of LV dysfunction is a common cause of pulmonary hypertension 21 which is the main cause of RV failure. 22 Our results reveal that for every 1 mm decrease in TAPSE there was an 11% increase in mortality in women (Table 3, model  2) . Moreover, abnormal TAPSE (TAPSE <17 mm) was associated with a greater risk of death in women compared with men ( Figure 5A and 5B).
In recent decades, RV systolic dysfunction has been pointed out as a predictor of morbidity and mortality in patients with HFrEF. 23, 24 Conventional measures are still the most widely used when evaluating RV function; nevertheless, TAPSE predominantly reflects the function of the basal segment of the RV free wall and may not be usable when regional dysfunction is involved. RV strain from 2-dimensional speckle tracking echocardiography provides a global evaluation of RV function, and the method has recently been pointed out as the most accurate and sensitive tool when estimating RV systolic function. 25 Moreover, RV strain is significantly associated with shorter survival in HF patients. 25 We found that RV GLS and RV FWS were significant predictors of mortality in the univariable analyses, applying to both genders (in women: P=0.002 and P=0.003, respectively). However, when including RV strain parameters in a multivariable model, HRs were insignificant. It seems that speckle tracking is a sensitive measure for early detection of RV dysfunction, but when RV dysfunction is already manifest the prognostic value of TAPSE is more robust.
Cause Behind Sex-Specific Differences
The reasons behind the sex differences observed in this study are not entirely clear. We know from previous studies that women with aging have more concentric remodeling and diastolic dysfunction compared with men. 4, 9 Furthermore, women are ≈2 times as likely as men to develop HF with preserved EF. 26 Impaired diastolic function including diastolic LV stiffening is consistent with well-established vascular biological factors where women are known to have smaller vessels 27 and more vascular stiffness. 2, 4, [9] [10] [11] [12] In a study of women taking androgens, treatment resulted in larger arteries compared with controls. 28 Similarly, men treated with estrogens displayed smaller arteries than control men. 29 In a study by Herity et al 30 female hearts transplanted into women showed little change over time, whereas when transplanted into men progressive coronary artery enlargement was observed independent of body size and LV size.
Thus, several studies support the notion of a link between arterial size and sex hormones. At the same time, it is believed that estrogens protect women from atherosclerotic disease. 31, 32 Mechanisms behind the cardioprotective properties of estrogens are still not fully understood; and recently, The Copenhagen Women Study found that cardiac dimensions and subclinical measures of cardiac function were similar in premenopausal and postmenopausal women, 33 conflicting with former views. 34 
Study Limitations
Our study lacks information on pulmonary hypertension, although this is closely associated with TAPSE and mortality. 35 Echocardiographic examination was not performed on the day of admittance. We excluded patients who had an echocardiographic examination performed >1 year from their first admittance (median: 30 days before admittance, interquartile range=6-56 days), however, there is a chance that cardiac structure and function had deteriorated and differed from the images that were analyzed.
Conclusions
TAPSE and IVRT were independent predictors of mortality in women, superior to both LVEF and GLS. LV systolic function was better preserved and diastolic function more impaired in women compared with men. Hence, in women with HFrEF RV function and LV diastolic function seem paramount in predicting mortality, whereas LV systolic function is more important in men.
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